Open AccessApplication of high technologies in modern diabetology
Author(s) -
E V Sakhabieva,
Shmuel Levit,
И Н Мусин,
M S Lisanevich,
E E Tsareva
Publication year - 2021
Publication title -
journal of physics. conference series
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 85
eISSN - 1742-6596
pISSN - 1742-6588
DOI - 10.1088/1742-6596/1889/5/052022
Subject(s) - diabetology , medicine , blood sugar , continuous glucose monitoring , blood glucose monitoring , therapeutic drug monitoring , intensive care medicine , metabolic disease , diabetes mellitus , continuous monitoring , type 1 diabetes , endocrinology , engineering , pharmacokinetics , operations management
Currently there are two types of devices determining blood glucose level on an ambulatory basis: self-monitoring of blood glucose using glucometers (Self-monitoring of blood glucose, SMBG) and various CGM devices (Continuous Glucose Monitoring) - continuous monitoring systems glucose. Nowadays CGM can definitely be called “ECG diabetes” and it is widely used in medical practice to treat the disease. Continuous monitoring of blood sugar level becomes the necessary tool for motivating people to change their lifestyle and it is very important component of effective treatment. With a therapeutic approach from the position of a “gravicentric concept” based on lowering glucose level by reducing the patient’s weight, remission of the disease and complete restoration of carbohydrate metabolism are no longer a myth. According to recent researches the transition of therapeutic goals from blood glucose targets (HBA1C) to metabolic goals (reducing body mass index - BMI) leads to quick results. The interpretation of CGM monitoring data based on a clinical example is described. CGM monitoring shows that in patients with T2DM the coefficient of variability is an easily accessible and most informative index confirming the restoration of functional abilities and secretion of endogenous insulin through metabolic recovery.